Schizophrenia trials in Brazil
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Brasília, Rio de Janeiro, São Paulo
- Age
- 55 years to 90 years
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - Phase 2Taking peopleA Study of Brenipatide in Adult Participants With Schizophrenia
- Where
- Belo Horizonte, Brasília, Campinas, Curitiba, Maringá, Natal, Rio de Janeiro, Salvador, São Paulo
- Age
- 18 years to 55 years
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07410507 - Phase 3Enrolling by invitationLong-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
- Where
- Curitiba, Fortaleza, Goiânia, Rio de Janeiro, São Paulo
- Age
- 10 years to 17 years
- People
- 236 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT04987229 - Phase 3Taking peopleStudy to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Where
- Curitiba, Fortaleza, Goiânia, Rio de Janeiro, São Paulo
- Age
- 10 years to 17 years
- People
- 220 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT05303064